PerkinElmer Inc (PKI)

NYSE
139.71
+2.21(+1.61%)
  • Volume:
    223,641
  • Bid/Ask:
    139.62/139.77
  • Day's Range:
    137.99 - 139.88

PKI Overview

Prev. Close
137.5
Day's Range
137.99 - 139.88
Revenue
4.44B
Open
138
52 wk Range
89.08 - 162.4
EPS
9.55
Volume
223,641
Market Cap
15.61B
Dividend (Yield)
0.28 (0.21%)
Average Vol. (3m)
966,654
P/E Ratio
14.39
Beta
1.11
1-Year Change
47.44%
Shares Outstanding
112,061,794
Next Earnings Date
Aug 05, 2021
What is your sentiment on PerkinElmer Inc?
or
Vote to see community's results!

PerkinElmer Inc News

  • PerkinElmer EPS beats by $0.65, beats on revenue
    • BySeeking Alpha-

    PerkinElmer (PKI): Q1 Non-GAAP EPS of $3.72 beats by $0.65; GAAP EPS of $3.37 beats by $0.78.Revenue of $1.31B (+100.7% Y/Y) beats by $100M.For the second quarter of 2021, the...

  • PerkinElmer Earnings, Revenue Beat in Q1
    • ByInvesting.com-

    Investing.com - PerkinElmer (NYSE:PKI) reported on Tuesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. PerkinElmer announced...

  • PerkinElmer declares $0.07 dividend
    • BySeeking Alpha-

    PerkinElmer (NYSE:PKI) declares $0.07/share quarterly dividend, in line with previous.Forward yield 0.21%Payable Aug.

PerkinElmer Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

PerkinElmer Inc Company Profile

PerkinElmer Inc Company Profile

PerkinElmer Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Its Discovery & Analytical Solutions segment serves the life sciences and applied markets. Through the Diagnostics Segment, it offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals. It provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its product under various brands, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, FragilEase, Genoglyphix, GSP, PG-Seq, PG-Find, Protein Clear, ProteinEXact and QSight, Glutomatic, Honigs Regression, HyperDSC, Inframatic, LAMBDA, NexION, NEN, OneSource, Opera Phenix, Operetta CLS and OsteoSense.

Read More
  • 97.50
    3
    • I thnk It will go up
      1
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.